Peer Review History
| Original SubmissionJune 4, 2025 |
|---|
|
Dear Dr. Alsaadi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 09 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Haipeng Liu Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in your Competing Interests section: “None” Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. 3. In the online submission form, you indicated that “It is available in the secure driver and upon request.” All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval. 4. Please include a separate caption for each figure in your manuscript. 5. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files" 6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: 1. Novelty and Significance Strength: The use of pixel-to-pixel wall thickness measurements and the focus on a Saudi population is novel and clinically relevant. Suggestion: The authors should more clearly articulate how this work advances the field beyond existing studies (e.g., Rogers et al., Pham et al., Haunschild et al.). Consider adding a brief comparison of values with existing datasets (e.g., Framingham Heart Study, Copenhagen General Population Study) in the Discussion. 2. Methodology – Imaging Analysis: The use of MATLAB for pixel-based segmentation is commendable. Concern: The algorithm for identifying inner and outer wall boundaries is not fully described. Was edge detection used? Manual or automated annotation? Suggestion: Include more detail in the Methods on image processing steps, validation of wall thickness measurements, and inter-observer variability assessment if applicable. 3. Statistical Analysis: The use of multiple linear regression is appropriate. Missing: Model diagnostics (e.g., R², residual analysis, multicollinearity checks) are not reported. Recommendation: Report variance inflation factors (VIFs) and standard errors for regression coefficients. This would strengthen the transparency and reliability of the findings. 4. Sample Representativeness: The study is based on data from a single tertiary center in Riyadh. Suggestion: Discuss the representativeness of the sample to the general Saudi population, including possible referral or selection bias due to the setting (i.e., imaging done for other indications). 5. Figure Presentation Strength: Figures 3–7 are visually informative. Improvement needed: Axes and legends in Figures 3–6 could be enlarged for clarity. Consider improving color contrast and label size in Figure 7. Suggestion: Add 95% confidence intervals or regression lines with shaded intervals where appropriate. 6. Discussion – Limitations While limitations are discussed, two important points are missing: - Radiation exposure from MDCT and its implications for routine use. - Exclusion of pathological cases (e.g., AAA, atherosclerosis), which limits clinical generalizability. 7. Terminology Consistency- Use consistent terminology (e.g., “lumen width” vs. “lumen area”) throughout. 8. BMI Formula: BMI = weight (kg)/height² (m²) — not the “Du Bois” formula. Du Bois is used for BSA. Please correct this. Reviewer #2: The authors present a single-centre retrospective analysis of a Saudi cohort undergoing MDCT, assessing abdominal aortic parameters in relation to BMI and gender. This is an important contribution, and the authors are to be commended for generating original data from an underrepresented population. 1- The study aims to (1) establish baseline abdominal aortic values and (2) correlate these with BMI and age to enhance a “diagnostic framework.” However, the term “enhancing diagnostic framework” is vague and should be more clearly defined. Given that many of the observed trends are expected, the rationale for the study should be revised in the introduction to reflect its actual contribution. 2- The claim that the Saudi population is underrepresented in vascular imaging studies should be supported by appropriate citations. Similarly, all assertive or general statements throughout the manuscript should be referenced. 3- The term “systemic diseases” used in the exclusion criteria requires clarification. Autoimmune conditions, which can affect vascular health, should be explicitly addressed. Since the scans were conducted on otherwise healthy individuals, the authors should also clarify the indications for MDCT, particularly in younger individuals, given that the study attempts to establish normative data. 4- As the data was collected from a single centre, generalizing the findings to the broader Saudi population may not be appropriate. Although this is acknowledged in the limitations section, the title should also be revised to reflect the single-centre nature of the study. 5- The use of nested parentheses in demographic data presentation (e.g., “111 (32%) male and 236 (68%) female”) can be improved for readability by using brackets: [111 (32%) male and 236 (68%) female]. This should be applied consistently throughout the manuscript. 6- The BMI calculation formula ("BMI = Weight (kg) / height (m²)") should be cited appropriately, especially if a standard formula such as Du Bois’ was used. 7- The manuscript focuses on a limited number of variables and may be more appropriate as a brief research letter under 1,000 words. This could improve the manuscript’s impact relative to its scope. [However, this might require a lot of work on the authors’ part and I leave this to the discretion of authors and editors. Authors may submit this manuscript as a revised version] 8- The correlation analysis does not support causal inference or predictive modeling. Phrasing such as “BMI emerged as a strong predictor” should be revised to reflect statistical correlation rather than predictive power. 9- The discussion would benefit from further elaboration on potential biological or pathophysiological explanations for the observed differences between genders and other subgroups. 10- It would be helpful if the authors could explain why only three parameters were included. If the choice was based on clinical relevance, data availability, or consistency with prior studies, this rationale should be clearly stated. Merits of the Manuscript: • The methodology appears sound and ethically appropriate. • The conclusions are well-supported by the data and not overstated. • Figures are of high quality and easy to interpret. • The manuscript is generally well-written and scientifically valid. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Jawad Basit ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Advanced MDCT Assessment of Abdominal Aortic Wall Integrity and Morphometry in the Saudi Cohort: A Single-Centre Cross-Sectional Study PONE-D-25-30079R1 Dear Authors, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Haipeng Liu Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: The authors have thoroughly addressed all previous comments and concerns raised during the initial review. The revised manuscript demonstrates clear improvements in methodological transparency, statistical reporting, figure clarity, and contextualization within the existing literature. All requested clarifications and corrections have been made, and the manuscript now meets the standards for scientific rigor and reporting. Reviewer #2: Thank you for inviting me to review this work. The authors have adequately addressed all my comments and I have no additional concerns. The authors are to congratulated for their exhaustive work and the paper can be accepted for publication in its current form. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Jawad Basit ********** |
| Formally Accepted |
|
PONE-D-25-30079R1 PLOS ONE Dear Dr. Alsaadi, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Haipeng Liu Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .